Contact
searchSearch
HMP Global
Login

ADHD Education Center Commentary

Stressed mother next to crib with baby
Commentary
Postpartum Distress in Women With ADHD: Risks, Recognition, and Evidence-Based Management
09/25/2025
This article explores the challenges of postpartum distress in women with ADHD, highlighting how symptoms and psychiatric comorbidities can intensify during pregnancy and the postpartum period. It reviews current evidence, treatment...
This article explores the challenges of postpartum distress in women with ADHD, highlighting how symptoms and psychiatric comorbidities can intensify during pregnancy and the postpartum period. It reviews current evidence, treatment...
This article explores the...
09/25/2025
Psych Congress Network
Rx pad in the shape of a cell phone with pills on the screen
Commentary
Telehealth Stimulant Prescribing and Substance Misuse Risk: What the Evidence Really Says
09/23/2025
This article reviews two large studies that evaluated whether telehealth prescribing of stimulants for ADHD increases substance misuse risk.
This article reviews two large studies that evaluated whether telehealth prescribing of stimulants for ADHD increases substance misuse risk.
This article reviews two large...
09/23/2025
Psych Congress Network
Hyper child jumps on couch while mom holds head in hands
Commentary
Beyond Symptoms: The Impact of Stigma in Families of Children With ADHD
09/19/2025
This article reviews how stigma affects families of children with ADHD—undermining help‑seeking, adherence, and well‑being—and offers clinician strategies to counter it, including destigmatizing language, brief caregiver screening, family...
This article reviews how stigma affects families of children with ADHD—undermining help‑seeking, adherence, and well‑being—and offers clinician strategies to counter it, including destigmatizing language, brief caregiver screening, family...
This article reviews how stigma...
09/19/2025
Psych Congress Network
a teenager's hand putting a bag of white pills into another teenager's hand.
Commentary
Understanding Abuse Potential Across ADHD Therapies: What Clinicians Need to Know
06/13/2025
As stimulant prescriptions for ADHD continue to rise, so does concern about their nonmedical use—particularly among adolescents and young adults.
As stimulant prescriptions for ADHD continue to rise, so does concern about their nonmedical use—particularly among adolescents and young adults.
As stimulant prescriptions for...
06/13/2025
Psych Congress Network
empty pill box on calendar with days crossed off
Commentary
Adherence and Acceptability: How Viloxazine ER Stacks Up Against Other ADHD Medications
06/13/2025
This article examines how viloxazine ER may improve adherence to ADHD treatment compared to other medications. As a non-stimulant with once-daily dosing, rapid onset, and low risk of misuse or cardiovascular issues, viloxazine ER addresses...
This article examines how viloxazine ER may improve adherence to ADHD treatment compared to other medications. As a non-stimulant with once-daily dosing, rapid onset, and low risk of misuse or cardiovascular issues, viloxazine ER addresses...
This article examines how...
06/13/2025
Psych Congress Network
A smily face button, post-it notes with A-D-H-D, and two puzzle pieces
Commentary
Combination Therapy in ADHD: When and How to Augment Treatment Safely
06/11/2025
As ADHD management becomes more nuanced, combination therapy is gaining attention as a pragmatic solution for patients who experience suboptimal outcomes or intolerable side effects on monotherapy.
As ADHD management becomes more nuanced, combination therapy is gaining attention as a pragmatic solution for patients who experience suboptimal outcomes or intolerable side effects on monotherapy.
As ADHD management becomes more...
06/11/2025
Psych Congress Network
Hand blocking small red sad face icons from large green smiling icon
Commentary
Viloxazine ER’s Impact on Comorbid Conditions: A Broader Approach to ADHD Management
06/05/2025
Managing attention-deficit/hyperactivity disorder (ADHD) often means navigating a maze of overlapping conditions—mood instability, anxiety, executive dysfunction, and more. This article explores how viloxazine ER, a non-stimulant with dual...
Managing attention-deficit/hyperactivity disorder (ADHD) often means navigating a maze of overlapping conditions—mood instability, anxiety, executive dysfunction, and more. This article explores how viloxazine ER, a non-stimulant with dual...
Managing...
06/05/2025
Psych Congress Network
Pharmacokinetics icon
Commentary
Pharmacokinetics of Viloxazine ER: What to Expect From Onset to Duration
06/05/2025
This article provides a practical breakdown of viloxazine ER’s absorption, metabolism, and elimination profiles, explaining how these features support its once-daily dosing and 24-hour symptom coverage.
This article provides a practical breakdown of viloxazine ER’s absorption, metabolism, and elimination profiles, explaining how these features support its once-daily dosing and 24-hour symptom coverage.
This article provides a...
06/05/2025
Psych Congress Network
A woman sleeping peacefully
Commentary
ADHD and Sleep: Why Non-Stimulants Might Be the Right Choice (Part 3)
06/02/2025
Sleep disturbances remain one of the most challenging aspects of ADHD management across all age groups, and stimulants, while effective for core symptoms, often exacerbate these issues.
Sleep disturbances remain one of the most challenging aspects of ADHD management across all age groups, and stimulants, while effective for core symptoms, often exacerbate these issues.
Sleep disturbances remain one of...
06/02/2025
Psych Congress Network
Blocks that spell ADHD with pills and a stethoscope
Commentary
The Rise of Non-Stimulant ADHD Treatments: A Paradigm Shift?
05/30/2025
This article explores the growing role of non-stimulant therapies for ADHD. With once-daily dosing, reduced risk for abuse, and greater suitability for patients with sleep disturbances or tics, non-stimulants offer compelling alternatives or...
This article explores the growing role of non-stimulant therapies for ADHD. With once-daily dosing, reduced risk for abuse, and greater suitability for patients with sleep disturbances or tics, non-stimulants offer compelling alternatives or...
This article explores the...
05/30/2025
Psych Congress Network

NEW FROM THE NP INSTITUTE ONLINE LEARNING HUB

andrew and julie
Rapid Refresh
Navigating Bipolar Disorder Treatment: Exploring the Role of Second-Generation Antipsychotics
04/11/2024

Featuring Andrew Penn, MS, PMHNP, and Julie Carbray, PhD, FPMHNP-BC, PMHCNS-BC, APRN

Featuring Andrew Penn, MS, PMHNP, and...
Andrew Penn, MS, PMHNP, and Julie Carbray, PhD, FPMHNP-BC, PMHCNS-BC, APRN, explore the nuanced role of second-generation antipsychotics in bipolar disorder treatment. They discuss the complexities of managing mania and depression phases and...
Andrew Penn, MS, PMHNP, and Julie Carbray, PhD, FPMHNP-BC, PMHCNS-BC, APRN, explore the nuanced role of second-generation antipsychotics in bipolar disorder treatment. They discuss the complexities of managing mania and depression phases and...
Andrew Penn, MS, PMHNP, and...
04/11/2024
Psych Congress NP Institute
Amber Hoberg
Rapid Refresh
Long-Acting Injectables for Adolescents With Schizophrenia and Schizoaffective Disorder
04/10/2024
Amber Hoberg, PMHNP-BC, navigates the complexities of adolescent psychosis treatment, exploring the potential benefits and considerations of LAIs for schizophrenia and schizoaffective disorder, while emphasizing evidence-based practice for...
Amber Hoberg, PMHNP-BC, navigates the complexities of adolescent psychosis treatment, exploring the potential benefits and considerations of LAIs for schizophrenia and schizoaffective disorder, while emphasizing evidence-based practice for...
Amber Hoberg, PMHNP-BC,...
04/10/2024
Psych Congress NP Institute
Hoberg and Matthews
Clinical Pearls
Tolerability Testing in Long-Acting Injectable Prescriptions
04/03/2024
Do clinicians need to test for tolerability before prescribing a long-acting injectable (LAI)? Desiree Matthews, PMHNP-BC, and Amber Hoberg, MSN, APRN, PMHNP-BC, offer their clinical insight.
Do clinicians need to test for tolerability before prescribing a long-acting injectable (LAI)? Desiree Matthews, PMHNP-BC, and Amber Hoberg, MSN, APRN, PMHNP-BC, offer their clinical insight.
Do clinicians need to test for...
04/03/2024
Psych Congress NP Institute

Sign Up

Psych Congress Network Newsletter

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2025 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use